Abstract:To the Editor: POU domain class 3 transcription factor 4 or BRN-4 (POU3F4) is a causative gene of non-syndromic X-linked hearing loss (HL), which is characterized by inner ear anomalies. To date, six X-linked non-syndromic HL loci (DFNX1-6) have been mapped to chromosome X and five of these genes have been identified: phosphoribosyl pyrophosphate synthetase 1 (PRPS1) (DFNX1, OMIM: 304500), POU3F4 (DFNX2, OMIM: 304400),[1] small muscle protein, X-linked (SMPX) (DFNX4, OMIM: 300066), apoptosis-inducing factor, mitochondria-associated, 1 (AIFM1) (DFNX5, OMIM: 300614), and collagen, type IV alpha-6 (COL4A6) (DFNX6, OMIM; 300914). POU3F4 mutation accounts for nearly 50% of all cases of DFNX.[2,3] The human POU3F4 gene is located in the Xq21.1 region with only one exon, encoding 361 amino acids. POU3F4 belongs to a superfamily of POU domain transcription factors, comprised of a POU-specific domain (75 amino acids) and a POU-homeodomain (63 amino acids), both of which influence DNA binding and specificity. The POU3F4 protein is involved in the development of the middle ear and inner ear, as well as some areas of the brain before birth.[4] However, HL is the only clinical phenotype observed in DFNX2 patients. So far, 72 different mutations in the coding region (57 mutations) and the putative regulatory element region (15 mutations) of the POU3F4 gene have been reported to be associated with non-syndromic HL in families with DFNX2. In this study, a new non-sense mutation in POU3F4 was analyzed and found to be associated with non-syndromic X-linked inheritance HL in a Chinese Han family. The proband, a 20-year-old male, presented to an otolaryngology clinic with congenital bilateral severe HL. The extended family of the proband is a three-generation Chinese family with fourteen family members, including five patients (four males: II: 2, II: 7, III: 4, and III: 5; and one female: II: 1) with HL and nine individuals (five males: I: 2, II: 4, II: 6, III: 1, and III: 2; and four females: I: 1, II: 3, II: 5, and III: 3) with normal hearing [Figure 1A]. The proband was subjected to detailed clinical evaluations. The otomicroscopical examination showed intact tympanic membranes and no middle ear effusion in the proband. The auditory brainstem response was not elicited by air conduction in the left ear and right ear at 105 dB normalized hearing level (dBnHL) [Figure 1B and 1C]. Further, high-resolution axial computed tomography scan revealed that there was no abnormal density in tympanic cavity and sinus, no obvious destruction of ossicular bone and surrounding bone wall, and symmetrical internal auditory canal on both sides. Bilateral inferior gyrus of cochlea was hypoplasia, spiral plate of inferior gyrus was absent, and direct communication existed between vestibule and inferior gyrus of cochlea [Figure 1D]. For a precise diagnosis, we performed whole-exome sequencing (WES) of the proband family members (II: 3, II: 4, and III: 4) and his uncle's family (II: 1, II: 2, and III: 1). Sequence analysis of DNA identified a novel hemizygous or heterozygous mutation (POU3F4; NM_000307.3; c.C76>T; p.Gln26*) [Figure 1E], which changes a glutamine (CAG) to a stop code (TAG) and is predicted to result in a truncated protein lacking POU3F4 transcription factor function [Figure 1F]. Sanger sequencing was used to identify the mutation for the family members (II: 1, II: 2, II: 3, II: 4, II: 5, III: 1, III: 2, III: 4, and III: 5). This mutation co-segregates with HL in male members of this family (II: 1, III: 4, and III: 5), and carried by maternal females with normal hearing (II: 3 and II: 5). Male members with normal hearing (II: 4, III: 1, and III: 2) did not carry this mutation. Member (II: 2) also did not have this mutation, though she suffered from HL at the age of 1 year. The non-sense mutation in POU3F4 was absent in the 250 healthy controls, indicating that it was not a mere polymorphism.Figure 1: The clinical features of the proband and mutation analysis. (A) Pedigree of the family. Circles represent females and squares represent males. Proband is marked with arrow. Members with HL are indicated with solid squares. Carrier females are marked in the pedigree (circles with dots). The incidence pattern of the pedigree shows X-linked hereditary. (B) Audiograms of the proband. The pure tone audiometry shows belated severe to profound HL. (C) The auditory brainstem response was not elicited by air conduction in the left ear and right ear at 105 dBnHL. (D) Temporal bone computed tomography of the proband demonstrates hypoplasia of cochlea and abnormal communication between the bottom of the internal auditory canal and the vestibule (red arrow head). All the findings were symmetric. (E) Sequencing chromatograms of POU3F4. The Sanger sequencing of proband and his family members. A heterozygous c.C76>T mutation was found in the female carriers and hemizygotic c.C76>T mutation was detected in the affected males. (F) A stop codon created by this POU3F4 mutation results in a truncated protein. dBnHL: dB normalized hearing level; HL: Hearing loss; POU3F4: POU domain class 3 transcription factor 4.A lack of functional POU3F4 protein probably disrupts the normal development of structures in the middle and inner ear, leading to HL.[4] Therefore, this mutation may be the cause of disease etiology of the pedigree. Patients with severe-to-profound hearing impairment due to POU3F mutation can benefit from cochlear implantation.[5] The proband (III: 4) underwent cochlear implantation after genetic and clinical diagnosis. Post-operative auditory performance demonstrated that he could respond to sounds. The effects of cochlear implantation and hearing evaluation are still under observation. His cousin (III: 5) also had unilateral cochlear implantation at age of 6 years before this genetic testing, and his language ability is developing well now. A perilymphatic flow (or “gusher”) is a common feature in inner ear surgery of patients with DFNX2. Based on the radiological findings and genetic diagnosis, we could properly deal with the “gusher” in cochlear implant surgery of the proband. Pedigree analysis is an important approach to search for the underlying cause of HL. However, it is not enough when small pedigrees or sporadic cases with indefinite inheritance pattern are present. WES accelerates the speed and accuracy of genetic analysis and improves the quality of genetic counseling. The younger generation members (III: 1, III: 2, and III: 3), urged to know the fate of their offspring since both of their parents exhibited congenital HL. The WES results clearly showed that they did not inherit the mutation from their father. However, they carried some potential variants from their mother. Although the cause of HL of their mother is not clear, the high-throughput sequencing technology is beneficial for medication guidance, genetic counseling, and marriage and parenting guidance, and therefore, will help to effectively prevent or reduce the occurrence of hereditary HL in this family. To our best knowledge, this novel mutation (c.C76>T; p.Gln26*) may be the first one in the coding region of the POU3F4 gene reported so far, according to the location. Another similar mutation (c.C79>T; p.Gln27*) was reported in a family from Poland.[6] It is worth noting that, in our report, the hearing ability of female carriers was normal, while the proband's mother harboring the heterozygous p.Gln27* mutation suffered from bilateral, pre-lingual, severe, and mixed type HL. A study on phenotype and genotype in females, unrelated mothers or sisters of boys presenting with typical DFNX2 phenotype due to POU3F4 mutants, showed that a late-onset HL was found in three of the eight patients carrying different mutants and only one had an inner ear malformation. The researchers concluded that no genotype/phenotype correlation was identified.[7] All reports on POU3F4 mutants in Chinese families demonstrated no penetrance in the carrier female members.[8,9] In this study, a novel non-sense mutation is identified in POU3F4 gene in a Chinese family with X-linked non-syndromic HL. Based on the results of molecular diagnosis and the clinical data, we provided genetic counseling for the family members. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Funding This work was supported by the grants from the State Key Program of National Natural Science Foundation of China (No. 81530029), the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 8171001156), the National Natural Science Foundation of China (No.81771007), and the National Natural Science Foundation of the State Youth Fund (No. 81800919). Conflicts of interest None.

The DFNA15 Deafness Mutation Affects POU4F3 Protein Stability, Localization, and Transcriptional Activity

Missense Mutations in Pou4f3 Cause Autosomal Dominant Hearing Impairment Dfna15 and Affect Subcellular Localization and Dna Binding

Cytoplasmic mislocalization of POU3F4 due to novel mutations leads to deafness in humans and mice

A Missense POU4F3 Variant Associated with Autosomal Dominant Midfrequency Hearing Loss Alters Subnuclear Localization and Transcriptional Capabilities.

Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein

Identification of two novel mutations in POU4F3 gene associated with autosomal dominant hearing loss in Chinese families

Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review

Novel POU3F4 variants identified in patients with inner ear malformations exhibit aberrant cellular distribution and lack of SLC6A20 transcriptional upregulation

A Novel Mutation Located in the N-Terminal Domain of MYO15A Caused Sensorineural Hearing Loss.

Clinical and molecular characterization of POU3F4 mutations in multiple DFNX2 Chinese families

A novel POU domain class 3 transcription factor 4 mutation causes X-linked non-syndromic hearing loss in a Chinese family.

Identification of a Novel Frameshift Variant of POU3F4 and Genetic Counseling of Korean Incomplete Partition Type III Subjects Based on Detailed Genotypes

Inhibition of Myo6 Gene Expression by Co-Expression of A Mutant of Transcription Factor Pou4f3 (Brn-3C) in Hair Cells

Molecular Analysis of the Pou3F4 Gene in Patients with Clinical and Radiographic Evidence of X-Linked Mixed Deafness with Perilymphatic Gusher

Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss

A POU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family

Pou3f4 deficiency causes defects in otic fibrocytes and stria vascularis by different mechanisms

Biochemical Characterization of the Mitochondrial Trnaser(ucn) T7511C Mutation Associated with Nonsyndromic Deafness

Novel domain-specific POU3F4 mutations are associated with X-linked deafness: examples from different populations

Identification of a novel mutation in POU3F4 for prenatal diagnosis in a Chinese family with X-linked nonsyndromic hearing loss

Exome sequencing identifies POU4F3 as the causative gene for a large Chinese family with non-syndromic hearing loss